# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001171843-25-007256
Filing Date
2025-11-13
Accepted
2025-11-13 07:31:34
Documents
47
Period of Report
2025-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | f8k_111325.htm iXBRL | 8-K | 15834
2 | PRESS RELEASE | exh_991.htm | EX-99.1 | 90535
3 | EXHIBIT 99.2 | exh_992.htm | EX-99.2 | 48688
4 |  | exh992_01.jpg | GRAPHIC | 58634
5 |  | exh992_02.jpg | GRAPHIC | 189709
6 |  | exh992_03.jpg | GRAPHIC | 162416
7 |  | exh992_04.jpg | GRAPHIC | 110272
8 |  | exh992_05.jpg | GRAPHIC | 172646
9 |  | exh992_06.jpg | GRAPHIC | 160971
10 |  | exh992_07.jpg | GRAPHIC | 185670
11 |  | exh992_08.jpg | GRAPHIC | 43751
12 |  | exh992_09.jpg | GRAPHIC | 145431
13 |  | exh992_10.jpg | GRAPHIC | 177389
14 |  | exh992_11.jpg | GRAPHIC | 152520
15 |  | exh992_12.jpg | GRAPHIC | 126546
16 |  | exh992_13.jpg | GRAPHIC | 163588
17 |  | exh992_14.jpg | GRAPHIC | 155940
18 |  | exh992_15.jpg | GRAPHIC | 168446
19 |  | exh992_16.jpg | GRAPHIC | 166337
20 |  | exh992_17.jpg | GRAPHIC | 166100
21 |  | exh992_18.jpg | GRAPHIC | 130512
22 |  | exh992_19.jpg | GRAPHIC | 119856
23 |  | exh992_20.jpg | GRAPHIC | 148630
24 |  | exh992_21.jpg | GRAPHIC | 127221
25 |  | exh992_22.jpg | GRAPHIC | 173192
26 |  | exh992_23.jpg | GRAPHIC | 145524
27 |  | exh992_24.jpg | GRAPHIC | 173770
28 |  | exh992_25.jpg | GRAPHIC | 177371
29 |  | exh992_26.jpg | GRAPHIC | 44996
30 |  | exh992_27.jpg | GRAPHIC | 173100
31 |  | exh992_28.jpg | GRAPHIC | 94213
32 |  | exh992_29.jpg | GRAPHIC | 115126
33 |  | exh992_30.jpg | GRAPHIC | 129234
34 |  | exh992_31.jpg | GRAPHIC | 132536
35 |  | exh992_32.jpg | GRAPHIC | 70699
| Complete submission text file | 0001171843-25-007256.txt |  | 6522639

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
36 | XBRL SCHEMA FILE | gnw-20250101.xsd | EX-101.SCH | 3402
37 | XBRL DEFINITION FILE | gnw-20250101_def.xml | EX-101.DEF | 26066
38 | XBRL LABEL FILE | gnw-20250101_lab.xml | EX-101.LAB | 35956
39 | XBRL PRESENTATION FILE | gnw-20250101_pre.xml | EX-101.PRE | 24702
49 | EXTRACTED XBRL INSTANCE DOCUMENT | f8k_111325_htm.xml | XML | 3312

Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 251475419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)